Table 2.
Activities against Gram-positive bacteria—minimal inhibitory concentrations (MIC, µg/mL) and diameter of growth inhibitory zone (GIZ, mm, applied 400 µg per disc).
| Strains | 6 | 14 | 15 | 19 | Ref. 1 |
|---|---|---|---|---|---|
| S. aureus NCTC 4163 | 6.25 (10) | 50 (13) | 50 (11) | 400 (12) | 0.25 (26) |
| S. aureus ATCC 25923 | 6.25 (15) | 50 (14) | 100 (11) | 400 (12) | 0.5 (26) |
| S. aureus ATCC 6538 | 12.5 (16) | 50 (13) | 50 (12) | 200 (11) | 0.25 (28) |
| S. aureus ATCC 29213 | 6.25 (15) | 50 (15) | 50 (11) | - | 0.5 (22) |
| S. epidermidis ATCC 12228 | 12.5 (16) | 50 (12) | - | - | 0.25 (30) |
| B. subtilis ATCC 6633 | 12.5 (15) | 50 (12) | 50 (15) | 400 (13) | <0.12 (38) |
| B. cereus ATCC 11778 | 6.25 (15) | 25 (15) | 50 (14) | 200 (13) | 0.25 (26) |
| M. luteus ATCC 9341 | 12.5 (15) | 200 (12) | 200 (13) | 200 (13) | 0.25 (26) |
| M. luteus ATCC 10240 | 6.25 (23) | 12.5 (20) | 50 (14) | 50 (14) | 1 (25) |
1 Ref.—ciprofloxacin (GIZ—5 µg/9 mm disc). Lack of the growth inhibition area.